The eye health dietary supplements market is growing rapidly. One market researcher recently predicted that the global market will be worth over $2.85 billion by 2024.1 The 2017 report by Persistence Market Research noted the consumer concerns driving market growth: “Prevalence of cataracts, macular degeneration, glaucoma, and many other eye diseases is prompting people to get eye health supplements prescribed from their ophthalmologists.” Even more specifically, the report predicted, more than two-thirds of eye health supplements produced around the world will be used by those concerned with age-related macular degeneration (AMD).
The report, which also took a deeper look at eye health supplement leaders like Vitabiotics, Valeant Pharmaceuticals International, Alliance Pharma, Novartis, Amway, Pfizer, and Nature’s Bounty, stated that North America will continue to lead the global eye health supplements market, with more than 30% revenue share. Strong growth is also predicted in Europe, as well as in Asia-Pacific, where Persistence predicted revenue will grow at 6.7% CAGR through 2024.
As for product manufacturing, Persistence said that lutein and zeaxanthin will remain core ingredients, accounting for more than 60% share of the market. “Demand for these ingredients will continue [to] gain traction during the forecast period,” the market researcher predicted.
These ingredients are especially crucial nutrients in the fight against AMD. “Dietary supplementation with lutein and zeaxanthin has been recommended for the prevention of AMD for more than 25 years, and it is still the most effective way to prevent, or delay, the onset of AMD,” says Cecilia McCollum, executive vice president of Blue California Ingredients (Rancho Santa Margarita, CA), supplier of the Biolut lutein ester ingredient with 2.5% zeaxanthin. “Loss of vision due to AMD is not reversible, so prevention is the only way to control the onset of the disease,” she adds.
As the eye health market evolves, newer concerns related to healthy vision, such as the damaging effect of blue light, are opening up new avenues in the market. One thing hasn’t changed, however: consumers are still demanding solutions backed by research and high-quality data. Here is a quick update on some of eye health’s biggest ingredient stars as well as developing market opportunities.
Photo © Shutterstock.com/Makistock
- “Eye health supplement market to reach US$2.85Bn by 2024 – Persistence Market Research.” PR Newswire. Published online March 14, 2017. https://www.prnewswire.com/news-releases/eye-health-supplements-market-to-reach-us-285-bn-by-2024---persistence-market-research-616113893.html
- Scripsema NK et al. “Lutein, zeaxanthin, and meso-zeaxanthin in the clinical management of eye disease.” Journal of Ophthalmology Special Issue: Zeaxanthin and Lutein in the Management of Eye Diseases. Published online December 24, 2015.
- Rinsky B et al. “Characterizing the effects of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration.” Molecular Vision. Published online December 6, 2017.
- Stringham JM et al. “Macular carotenoid supplementation improves visual performance, sleep quality, and adverse physical symptoms in those with high screen time exposure.” Foods. Published online June 29, 2017.
- Yu M et al. “Lutein and zeaxanthin isomers protect against light-induced retinopathy via decreasing oxidative and endoplasmic reticulum stress in BALB/cJ mice.” Nutrients. Published online ahead of print June 28, 2018.